Company: TCBI
Filing Date: 2025-03-06
Form Type: DEF 14A
Source: 0001077428-25-000066
Chunk: 109

Company: TEXAS CAPITAL BANCSHARES INC/TX
Filing Date: 2025-03-06
Form: DEF 14A
Chunk 109
---
 for an additional 1.1 million shares and a two-year extension of the expiration date of the 2022 Plan, to April 19, 2034, is reasonable and necessary to allow the Company to replenish the share usage since the Company last sought approval of a share increase (in the form of the original adoption of the 2022 Plan), to continue the Compensation Committee’s current grant practices in the future to attract and retain individuals on whom the Company’s success is dependent and to be able to respond to growth (both organic and inorganic), and potential stock price fluctuations.

TCBI 2025 | Notice of Annual Meeting and Proxy Statement 101

| 2022 Long-Term Incentive Plan, As Amended and Restated |

#### Important Information About the Amended 2022 Plan
Key Data Used to Determine the Number of Shares Needed

Outstanding Equity Awards and Shares Available . The following table includes information regarding equity awards and shares available for future awards under the 2022 Plan, as of December 31, 2024:

| Total shares underlying outstanding stock options                                                                                                           |     | 2022 Plan | — |            |
|:------------------------------------------------------------------------------------------------------------------------------------------------------------|:----|----------:|:--|-----------:|
| Weighted-average exercise price of outstanding stock options                                                                                                |     |         $ | — |            |
| Weighted-average remaining contractual life of outstanding stock options (in years)                                                                         |     |           | — |            |
| Total shares underlying outstanding unvested full value awards (including time- and performance-based restricted stock unit awards (with PRSUs at maximum)) |     |           |   |    854,651 |
| Total shares available for grant (A)                                                                                                                        |     |           |   |    249,423 |
| Common Stock outstanding as of December 31, 2024                                                                                                            |     |           |   | 46,233,812 |
| Market price of Common Stock as of December 31, 2024                                                                                                        |     |    $78.20 |   |            |

(A) Reflects shares available for issuance under the 2022 Plan as currently constituted.

The following information is provided concerning the Company’s equity awards over the last three years:

| Stock-Settled            
 Restricted Stock Units   |     | 

# of Shares / Units    |     |          |       |     |         |     |           |
| Time-Based               
 RSUs                     |     | Performance-Based RSUs